1,035
Views
2
CrossRef citations to date
0
Altmetric
Short Communication

Clinicopathological Profile and Outcomes of Anorectal Melanoma From a Tertiary Care Center in India

ORCID Icon, ORCID Icon, , , , , , & show all
Article: FSO786 | Received 02 Aug 2021, Accepted 19 Jan 2022, Published online: 10 Feb 2022

References

  • ChangAE , KarnellLH , MenckHR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer83(8), 1664–1678 (1998).
  • McLaughlinCC , WuX-C , JemalA , MartinHJ , RocheLM , ChenVW. Incidence of noncutaneous melanomas in the U.S. Cancer103(5), 1000–1007 (2005).
  • CagirB , WhitefordMH , TophamA , RakinicJ , FryRD. Changing epidemiology of anorectal melanoma. Dis. Colon Rectum42(9), 1203–1208 (1999).
  • BelloDM , SmythE , PerezDet al.Anal versus rectal melanoma: does site of origin predict outcome?Dis. Colon Rectum56(2), 150–157 (2013).
  • DumazN , JouenneF , DelyonJ , MourahS , BensussanA , LebbéC. Atypical BRAF and NRAS mutations in mucosal melanoma. Cancers11(8), 1133 (2019).
  • JohnsonDB , CarlsonJA , ElvinJAet al.Landscape of genomic alterations (GA) and tumor mutational burden (TMB) in different metastatic melanoma (MM) subtypes. J. Clin. Oncol.35(Suppl. 15), 9536–9536 (2017).
  • LianB , CuiCL , ZhouLet al.The natural history and patterns of metastases from mucosal melanoma: an analysis of 706 prospectively-followed patients. Ann. Oncol.28(4), 868–873 (2017).
  • CurtinJA , FridlyandJ , KageshitaTet al.Distinct sets of genetic alterations in melanoma. N. Engl. J. Med.353(20), 2135–2147 (2005).
  • OmholtK , GrafströmE , Kanter-LewensohnL , HanssonJ , Ragnarsson-OldingBK. KIT pathway alterations in mucosal melanomas of the vulva and other sites. Clin. Cancer Res.17(12), 3933–3942 (2011).
  • Gutiérrez-CastañedaLD , NovaJA , Tovar-ParraJD. Frequency of mutations in BRAF, NRAS, and KIT in different populations and histological subtypes of melanoma: a systemic review. Melanoma Res.30(1), 62–70 (2020).
  • SantiR , SimiL , FucciRet al.KIT genetic alterations in anorectal melanomas. J. Clin. Pathol.68(2), 130–134 (2015).
  • BeadlingC , Jacobson-DunlopE , HodiFSet al.KIT gene mutations and copy number in melanoma subtypes. Clin. Cancer Res.14(21), 6821–6828 (2008).
  • ChuteDJ , CousarJB , MillsSE. Anorectal malignant melanoma: morphologic and immunohistochemical features. Am. J. Clin. Pathol.126(1), 93–100 (2006).
  • CharifaA , ZhangX. Morphologic and immunohistochemical characteristics of anorectal melanoma. Int. J. Surg. Pathol.26(8), 725–729 (2018).
  • HicksCW , PappouEP , MagruderJTet al.Clinicopathologic presentation and natural history of anorectal melanoma: a case series of 18 patients. JAMA Surg.149(6), 608–611 (2014).
  • SingerM , MutchMG. Anal melanoma. Clin. Colon Rectal Surg.19(2), 78–87 (2006).
  • BishopKD , OlszewskiAJ. Epidemiology and survival outcomes of ocular and mucosal melanomas: a population-based analysis. Int. J. Cancer134(12), 2961–2971 (2014).
  • DasG , GuptaS , ShuklaPJ , JagannathP. Anorectal melanoma: a large clinicopathologic study from India. Int. Surg.88(1), 21–24 (2003).
  • RamakrishnanAS , MahajanV , KannanR. Optimizing local control in anorectal melanoma. Indian J. Cancer45(1), 13–19 (2008).
  • RanjithS , MuraleeM , SajeedAet al.Anorectal melanoma: experience from a tertiary cancer care centre in South India. Ann. R. Coll. Surg. Engl.100(3), 185–189 (2018).
  • HepptMV , RoeschA , WeideBet al.Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma. Eur. J. Cancer81, 36–44 (2017).
  • PessauxP , PocardM , EliasDet al.Surgical management of primary anorectal melanoma. Br. J. Surg.91(9), 1183–1187 (2004).
  • FalchC , StojadinovicA , Hann-von-WeyhernCet al.Anorectal malignant melanoma: extensive 45-year review and proposal for a novel staging classification. J. Am. Coll. Surg.217(2), 324–335 (2013).
  • IddingsDM , FleisigAJ , ChenSL , FariesMB , MortonDL. Practice patterns and outcomes for anorectal melanoma in the USA, reviewing three decades of treatment: is more extensive surgical resection beneficial in all patients?Ann. Surg. Oncol.17(1), 40–44 (2010).
  • CheX , ZhaoD-B , WuY-Ket al.Anorectal malignant melanomas: retrospective experience with surgical management. World J. Gastroenterol.17(4), 534–539 (2011).
  • WeyandtGH , EggertAO , HoufM , RaulfF , BröckerEB , BeckerJC. Anorectal melanoma: surgical management guidelines according to tumour thickness. Br. J. Cancer89(11), 2019–2022 (2003).
  • NakhlehRE , WickMR , RocamoraA , SwansonPE , DehnerLP. Morphologic diversity in malignant melanomas. Am. J. Clin. Pathol.93(6), 731–740 (1990).
  • IddingsDM , FleisigAJ , ChenSL , FariesMB , MortonDL. Practice patterns and outcomes for anorectal melanoma in the USA, reviewing three decades of treatment: is more extensive surgical resection beneficial in all patients?Ann. Surg. Oncol.17(1), 40–44 (2010).
  • DroeschJT , FlumDR , MannGN. Wide local excision or abdominoperineal resection as the initial treatment for anorectal melanoma?Am. J. Surg.189(4), 446–449 (2005).
  • D'AngeloSP , LarkinJ , SosmanJAet al.Efficacy and safety of nivolumab alone or in combination with ipilimumab in patients with mucosal melanoma: a pooled analysis. J. Clin. Oncol.35(2), 226–235 (2017).
  • HamidO , RobertC , RibasAet al.Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006. Br. J. Cancer119(6), 670–674 (2018).
  • IddingsDM , FleisigAJ , ChenSL , FariesMB , MortonDL. Practice patterns and outcomes for anorectal melanoma in the USA, reviewing three decades of treatment: is more extensive surgical resection beneficial in all patients?Ann. Surg. Oncol.17(1), 40–44 (2010).